<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[vitro diagnostics inc. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/vitro+diagnostics+inc..html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to vitro diagnostics inc.]]></description>
	<s:counts start="0" returned="20" found="26" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Adaltis Inc. Provides Update on its Activities and Financing Requirements]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200904/ai_n31596474]]></link>
		<description><![CDATA[  Adaltis Inc. (TSX: ADS), an international in vitro diagnostic IVD company wishes to communicate recent changes in its key leadership team and recent developments in its business prospects.  The Corporation previously announced in February 2009 the appointment of Mr. Peter Bambic as President and Chief Executive Officer...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 29 Apr 2009 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/adaltis+inc..html"><![CDATA[Adaltis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADS</category>
		<category domain="tickers">ADS</category>
	</item>
	<item>
		<title><![CDATA[Adaltis Inc. Provides Update on its Activities and Financing Requirements.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200904/ai_n31624347]]></link>
		<description><![CDATA[  MONTREAL, QUEBEC, Apr 29, 2009 Marketwire via COMTEX -- Adaltis  Inc. (TSX:ADS), an international in vitro diagnostic IVD company  wishes to communicate recent changes in its key leadership team and  recent developments in its business prospects.    The Corporation previously announced in February...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 29 Apr 2009 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/adaltis+inc..html"><![CDATA[Adaltis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADS</category>
		<category domain="tickers">ADS</category>
	</item>
	<item>
		<title><![CDATA[Asuragen Signs Armored RNAŽ Licensing Agreement with Focus Diagnostics]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Sept_9/ai_n28073833]]></link>
		<description><![CDATA[AUSTIN, Texas & CYPRESS, Calif. -- Asuragen, Inc., announces that it has granted Focus Diagnostics, Inc., the infectious disease diagnostics company of Quest Diagnostics, non-exclusive worldwide rights to incorporate Armored RNA([R]) technology into its in vitro molecular diagnostics products. Under the terms of the Agreement, Asuragen will develop and supply...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 09 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/focus+diagnostics+inc..html"><![CDATA[Focus Diagnostics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[IRIS Awarded Gold Vendor Designation by MedAssets Supply Chain Systems]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_2/ai_n25471331]]></link>
		<description><![CDATA[CHATSWORTH, Calif. -- Iris Diagnostics, a division of IRIS INTERNATIONAL, INC. (NASDAQ: IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that it has earned MedAssets Supply Chain Systems Gold Vendor Award, one of the highest vendor designations...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/hospital.html"><![CDATA[hospital]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[IRIS To Present at Morgan Stanley Global Healthcare Unplugged Conference May 1, 2008]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_9/ai_n25131810]]></link>
		<description><![CDATA[CHATSWORTH, Calif. -- IRIS INTERNATIONAL, INC. (NASDAQ GM: IRIS), a leading developer and manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that Chairman, President and Chief Executive Officer Cesar Garcia will present an overview of the Company at the Morgan...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 09 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
		<category domain="tickers">MS</category>
	</item>
	<item>
		<title><![CDATA[QIAGEN expands its portfolio of licenses to real-time PCR.(real-time polymerase chain reaction agreement with Roche Biomedical Laboratories Inc.)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6487/is_200704/ai_n25822408]]></link>
		<description><![CDATA[QIAGEN N.V. (Venlo, The Netherlands), the worldwide leading  provider of sample and assay technologies for research in life sciences,  applied testing and molecular diagnostics announced that it has acquired  licenses from Roche, as well as from Ortho Clinical Diagnostics. These  two license agreements significantly expand QIAGEN's...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 01 Apr 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/qiagen+n.v..html"><![CDATA[QIAGEN N.V.]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Epigenomics AG and Affymetrix Announce Strategic Diagnostics Platform Agreement]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_June_27/ai_n26908690]]></link>
		<description><![CDATA[BERLIN & SEATTLE, & SANTA CLARA, Calif. -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, and Affymetrix Inc. (NASDAQ:AFFX) announced today that Affymetrix has granted Epigenomics non-exclusive access to Affymetrix microarray technology to develop and market microarray-based in-vitro diagnostic IVD tests...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 27 Jun 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Fujirebio Diagnostics Chief Scientific Officer Named to Immunology Devices Panel Of the Medical Devices Advisory Committee; Committee Offers Independent Professional and Technical Advice to U.S. FDA]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_May_2/ai_n26846257]]></link>
		<description><![CDATA[MALVERN, Pa. -- Fujirebio Diagnostics, Inc. FDI, a world-leader in in-vitro diagnostics, today announced that its vice president and chief scientific officer, Dr. W. Jeffrey Allard, has been named as an industry representative to the Immunology Devices Panel of the Medical Devices Advisory Committee, a group of outside experts that...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 02 May 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Vitro and PhosphoSolutions Collaborate to Study Stem Cell Proteomics]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200601/ai_n15991786]]></link>
		<description><![CDATA[Vitro Diagnostics, Inc. (OTC BB: VODG), dba Vitro Biopharma, announced establishment of research collaboration with PhosphoSolutions, LLC Aurora Colorado to characterize intracellular signaling mechanisms involved with regulation of stem cell growth and differentiation.  Vitro has previously developed 29 adult pancreatic stem cell lines and has developed methodologies to induce...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 11 Jan 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/differentiation.html"><![CDATA[differentiation]]></category>
		<category domain="http://resources.bnet.com/topic/stem-cell.html"><![CDATA[stem-cell]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Affymetrix and PathWork Informatics Forge Collaboration to Develop New Cancer Diagnostics]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Nov_1/ai_n15765540]]></link>
		<description><![CDATA[SANTA CLARA, Calif. & SAN JOSE, Calif. -- Affymetrix Inc. (Nasdaq:AFFX) and PathWork Informatics Inc. announced today that Affymetrix has granted PathWork long-term non-exclusive access to its microarray technology to develop and market in-vitro diagnostic tests for cancer. Under the agreement, PathWork has the right to use Affymetrix microarray technology...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Nov 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Vitro Signs Letter of Intent to Form Strategic Alliance With European Biotechnology Firm]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200509/ai_n15405014]]></link>
		<description><![CDATA[Vitro Diagnostics, Inc. (OTC BB: VODG), a biotechnology company, executed a binding letter of intent to form a broad-ranging strategic alliance with BioCare Europe headquartered in Rome, Italy.  The partnership includes various agreements with regard to commercialization of Vitro's stem cell lines for use in research and development and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 21 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/strategic+alliance.html"><![CDATA[strategic alliance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Bruker Daltonics Obtains South Korean Registration of autoflex II MALDI-TOF Mass Spectrometer as Class I Medical Device for IVD]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_August_10/ai_n14875666]]></link>
		<description><![CDATA[SEOUL, Republic of Korea & BILLERICA, Mass. -- Bruker Daltonics Inc. today announces that it has obtained registration of its leading autoflexR II MALDI-TOF mass spectrometers as Class I Medical Devices with the Korea Food and Drug Administration.  MALDI-TOF mass spectrometry is increasingly being applied to the areas of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 10 Aug 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bruker+daltonics+inc..html"><![CDATA[Bruker Daltonics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Renovar Presents Data on New Kidney Diagnostic at American Transplantation Congress]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_May_25/ai_n13778541]]></link>
		<description><![CDATA[MADISON, Wis. -- Renovar, Inc., an in vitro diagnostics company, announced results of its new test for kidney transplant patients, at the American Transplantation Congress in Seattle, Washington. The meeting is the Joint Annual Meeting of the American Societies of Transplant Surgeons and Transplantation.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 25 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Vitro Establishes US East Coast Operations]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_April_19/ai_n13631375]]></link>
		<description><![CDATA[AURORA, Colo. -- Vitro Diagnostics, Inc. (OTCBB: VODG - News), a biotechnology company, announced establishment of east coast operations in central New Jersey. This facility will manage business development and fund raising activities of the Company while corporate headquarters, research & development and manufacturing operations will continue in Colorado. ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 19 Apr 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/us+east+inc..html"><![CDATA[US East Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Analysis Leads Roche Diagnostics to Select FalconStor's VirtualTape Library for Rapid Backup and Restore Capabilities; VTL Appliance Simplifies Backup of 85 Terabytes of Storage for Healthcare Group Division]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_March_8/ai_n11853630]]></link>
		<description><![CDATA[MANNHEIM, Germany -- FalconStor Software, Inc. (Nasdaq: FALC), a leading developer of network storage software solutions, today announced that Roche Diagnostics GmbH in Mannheim, a world leader in in-vitro diagnostics, has chosen FalconStor's VirtualTape Library VTL solution to simplify and accelerate backup and restore operations for a 2 Gigabit Fibre...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 08 Mar 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[analysis]]></category>
		<category domain="http://resources.bnet.com/topic/backup.html"><![CDATA[backup]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/storage.html"><![CDATA[storage]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[TheraDoc Powers bioMerieux's New Clinical Intervention Software System, STELLARA]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_June_22/ai_n6084935]]></link>
		<description><![CDATA[SALT LAKE CITY -- Customization of TheraDoc's Clinical Decision-Support Technology Results in Smarter Microbiology Diagnostics for North American Hospitals  TheraDocR, Inc., a Utah-based medical informatics company specializing in clinical decision-support technologies, has signed an industry exclusive agreement with bioMerieux, Inc., an international leader in the field of in vitro...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 22 Jun 2004 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biomerieux+inc..html"><![CDATA[bioMerieux Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Vitro's cell immortalization patent allowed.(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6487/is_200206/ai_n25823325]]></link>
		<description><![CDATA[Vitro Diagnostics, Inc. (Aurora, CO; 720-859-4120) announced the  receipt of a "Notice of Allowance" from the United States  Patent and Trademark Office for a patent application entitled,  "Immortalized Cell Lines and Methods of Making the Same."  During the mid-1990's, the company developed novel technology that ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 01 Jun 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Ambion, Inc - Brief Article]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m3230/is_6_32/ai_63694154]]></link>
		<description><![CDATA[Ambion, Inc. has granted Abbott Laboratories nonexclusive rights to use Ambion's Armored RNA technology in products and processes for in vitro diagnostics. Under the terms of the agreement, Abbott can manufacture Armored RNA controls and standards for  Use in its diagnostic kits. Armored RNA technology was developed by Ambion...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 01 Jul 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ambion+inc..html"><![CDATA[Ambion Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Ambion, Inc - Brief Article]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m3230/is_6_32/ai_64263307]]></link>
		<description><![CDATA[Ambion, Inc. has granted Abbott Laboratories nonexclusive rights to use Ambion's Armored RNA technology in products and processes for in vitro diagnostics. Under the terms of the agreement, Abbott can manufacture Armored RNA controls and standards for use in its diagnostic kits. Armored RNA technology was developed by Ambion and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Jun 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ambion+inc..html"><![CDATA[Ambion Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Beckman Coulter Signs Contract With U.S. Veterans Administration]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1999_Dec_1/ai_57889344]]></link>
		<description><![CDATA[FULLERTON, Calif.--BUSINESS WIRE--Dec. 1, 1999--  Beckman Coulter Inc. (NYSE:BEC) Wednesday announced that the company has received a five-year contract from the Veterans Administration that includes in vitro diagnostics instruments, service and consumable products.  Anticipated revenues will be in excess of $100 million over the contract term, which runs...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Dec 1999 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/beckman+coulter+inc..html"><![CDATA[Beckman Coulter Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+wire.html"><![CDATA[Business Wire]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BEC</category>
		<category domain="tickers">BEC</category>
	</item>
</channel>
</rss>
